This content is machine translated Urothelial carcinoma of the urinary bladder A challenge even in times of immune checkpoint inhibitors Urothelial carcinoma accounts for 90% of urinary bladder tumors. Every year, 1250 people in Switzerland contract the disease – predominantly older men. Standard treatment is cisplatin-containing chemotherapy. Immunotherapy is playing…
View Post 4 min This content is machine translated Checkpoint Inhibitors Urothelial carcinoma of the urinary bladder – system therapy in transition Checkpoint inhibitors have now become established as a new therapeutic standard in the second-line treatment of metastatic urothelial carcinoma. However, its use could also be useful in first-line therapy.
View Post 8 min This content is machine translated Female urinary incontinence Not every patient understands the same Urinary incontinence creates a high level of suffering. Yet many sufferers are reluctant to seek help. Less than half of the affected women want to talk about it, even though…
